Consultation on Proposed Amendments to the Pharmaceutical Regulation for Pneumococcal Vaccines 

Proposed amendments to the Pharmaceutical Regulation invite consultation on enabling pharmacists to administer new pneumococcal vaccines and updating the definition of "hospital."

Manitoba Health, Seniors and Long-Term Care (MHSLTC) has proposed amendments to the Pharmaceutical Regulation to enable injection certified pharmacists to administer the new publicly funded pneumococcal vaccines, and to update the definition of “hospital.” 

 Proposed Amendments: 

  1. Amendment to Schedule 2: This amendment will allow pharmacists to administer any of the two publicly funded pneumococcal vaccines, as well as any future publicly funded pneumococcal vaccines.
  2. Update to Hospital Definition: The definition of “hospital” in the Pharmaceutical Regulation will be updated to reference the Health Services Insurance Act instead of “The Hospitals Act”. 

You can access the proposed amendments here.

Background Information: 

Due to recent updates in the Pneumococcal Immunization Program, the Pneumococcal 23-Valent Polysaccharide (Pneu-P-23) vaccine is no longer available for pharmacists to order or administer. The proposed amendments will enable pharmacists to continue providing essential immunizations to patients. 

Feedback Submission:  

The CPhM Council has approved a 15-day public consultation period for these draft regulation amendments. We encourage you to review the proposed changes and provide your feedback. Comments can be submitted via email with the subject line ‘ Consultation Feedback’ to feedback@cphm.ca by August 15, 2024.